Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents [Phase 2]

View source ↗

Summary

This Phase 2 trial compares safety and efficacy of fixed-dose titration versus individualized-dose titration of SHR-3167 in adults with type 2 diabetes inadequa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR-3167

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: NOT_YET_RECRUITING